PCA Investment Advisory Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,311
Closed -$334K 100
2024
Q4
$334K Sell
2,311
-147
-6% -$22.8K 0.15% 88
2024
Q3
$398K Buy
2,458
+92
+4% +$14.7K 0.19% 79
2024
Q2
$346K Sell
2,366
-179
-7% -$26.6K 0.18% 78
2024
Q1
$403K Buy
2,545
+637
+33% +$101K 0.23% 64
2023
Q4
$299K Buy
1,908
+7
+0.4% +$1.07K 0.2% 73
2023
Q3
$296K Buy
1,901
+6
+0.3% +$990 0.21% 75
2023
Q2
$314K Sell
1,895
-435
-19% -$70.2K 0.19% 75
2023
Q1
$361K Buy
+2,330
New +$376K 0.26% 66

Other funds holding JNJ

PCA Investment Advisory Services's JNJ Position: Q1 2025 in Review

PCA Investment Advisory Services sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 2,311 shares — an estimated $334K sold.

PCA Investment Advisory Services first reported a position in JNJ in Q1 2023 and held it in 8 quarters. The position peaked at $403K in Q1 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • PCA Investment Advisory Services reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • PCA Investment Advisory Services sold 2,311 Johnson & Johnson shares in Q1 2025, an estimated $334K.
  • PCA Investment Advisory Services first reported a position in Johnson & Johnson in Q1 2023 and held it in 8 quarters.
  • PCA Investment Advisory Services's Johnson & Johnson position peaked at $403K in Q1 2024.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on PCA Investment Advisory Services's 13F filing for Q1 2025, filed 5 May 2025.